Chemomab Therapeutics (CMMB) has released an update.
Chemomab Therapeutics Ltd., a biotech firm, announced the approval of key shareholder resolutions during its annual general meeting held on June 10, 2024. Shareholders voted in favor of re-electing Dr. Alan Moses and Dr. Adi Mor as directors, increasing the authorized share capital, and reappointing Somekh Chaikin of KPMG as the independent auditor for the fiscal year. These decisions are set to steer the company’s direction and financial health in the upcoming year.
For further insights into CMMB stock, check out TipRanks’ Stock Analysis page.
